FRACANZANI, ANNA LUDOVICA
FRACANZANI, ANNA LUDOVICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study]
2021 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis
2010 A. Auinger, L. Valenti, M. Pfeuffer, U. Helwig, J. Herrmann, A.L. Fracanzani, P. Dongiovanni, S. Fargion, J. Schrezenmeir, D. Rubin
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
2014 L. Valenti, A.L. Fracanzani, P. Dongiovanni, S. Rovida, R. Rametta, E. Fatta, E.A. Pulixi, M. Maggioni, S. Fargion
A sweet fever
2019 S. Tiraboschi, A.V. Marzano, R. Lombardi, G. Genovese, G. Boccoli, S. Fargion, A.L. Fracanzani
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype
2011 E. Galmozzi, B. Del Menico, R. Rametta, P. Dongiovanni, A. L. Fracanzani, L. Benedan, V. Borroni, P. Maggioni, S. R. Fargion, L. V. C. Valenti
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease
2007 L. Valenti, P. Dongiovanni, A. Piperno, A. L Fracanzani, R. Rametta, P. Trombini, S. Fargion
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma
2011 M. Sampietro, A.L. Fracanzani, D. Tavazzi, A. Cespiati, C. Bertelli, D. Bignamini, L.V.C. Valenti, S.R. Fargion
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease
2018 A. Pigoni, F. Iuculano, C. Saetti, L. Airaghi, L. Burdick, S. Spreafico, M. Curioni, R. Lombardi, L. Valenti, A..L. Fracanzani, S. Fargion
Acute Kidney Injury in Non-Intensive Care Unit (ICU) Hospitalizations for Coronavirus Disease (COVID-19)
2022 F. Fabrizi, C.M. Alfieri, P. Molinari, F. Tamborini, M. Tangredi, A. Sikharulidze, F. Blasi, A. Fracanzani, W. Monzani, F. Peyvandi, G. Castellano
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion, L.V.C. Valenti
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 L.V.C. Valenti, R. Rametta, M. Ruscica, E. Canavesi, A.L. Fracanzani, P. Dongiovanni, P. Magni, S.R. Fargion
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 L.V.C. Valenti, R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study
2021 G. Bozzi, D. Mangioni, F. Minoia, S. Aliberti, G. Grasselli, L. Barbetta, V. Castelli, E. Palomba, L. Alagna, A. Lombardi, R. Ungaro, C. Agostoni, M. Baldini, F. Blasi, M. Cesari, G. Costantino, A.L. Fracanzani, N. Montano, V. Monzani, A. Pesenti, F. Peyvandi, M. Sottocorno, A. Muscatello, G. Filocamo, A. Gori, A. Bandera
Analisis of HLA-H mutations in italian patients with genetic hemochromatosis: Evidence of genetic heterogeneity
1997 A. Piperno, M. Sampietro, A. Vergani, C. Arosio, L. Lupica, P. Pasquero, I. Malosio, C. Nicoli, P. Cerutti, A.L. Fracanzani, D. Girelli, A. Roetto, P. Gasparini, S. Fargion, C. Camaschella
ANALYSIS OF FERRITIN DISTRIBUTION IN THE LIVER AND IN THE GASTRIC AND DUODENAL MUCOSA OF PATIENTS WITH IDIOPATHIC HEMOCHROMATOSIS
1988 A.L. Fracanzani, S.R. Fargion, A. Piperno, R. Romano, G. Ronchi, G. Fiorelli
Are the determinants of steatosis Associated with chronic hepatitis C( CHC) different from those of non alcoholic fatty liver disease ( NAFLD? )
2006 E.A. Pulixi, A.L. Fracanzani, A. Maraschi, C. Bertelli, S.R. Fargion
Association between heterozygosity for HFE gene mutations and hepatis viruses in hepatocellular carcinoma
2005 A.L. Fracanzani, S.R. Fargion, M.A. Stazi, L.V.C. Valenti, P. Amoroso, E. Cariani, A. Sangiovanni, M. Tommasini, A. Rossini, C. Bertelli, E. Fatta, V. Patriarca, S. Brescianini, T. Stroffolini
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
2008 L. Valenti, M. Varenna, A.L. Fracanzani, V. Rossi, S. Fargion, L. Sinigaglia
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
2008 L. Valenti, M. Varenna, A.L. Fracanzani, V. Rossi, S. Fargion, L. Sinigaglia
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
2009 L.V.C. Valenti, M. Varenna, A.L. Fracanzani, V. Rossi, S.R. Fargion, L. Sinigaglia